author-photo

Neelima Vidula

Harvard University

68

Papers

359

Citations

Citation Trend

Filter By

Papers (42) Sort By

Journal Conference Others

A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast Cancer.

2021 Clinical Breast Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PS18-19: Comparison of metastatic genomic profile in patients ≤45 years and patients >45 years with triple-negative breast cancer

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types

2021 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (2)
Tumor tissue- versus plasma-based genotyping for selection of matched therapy and impact on clinical outcomes in patients with metastatic breast cancer.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Abstract OT-13-09: Translational breast cancer research consortium 044 trial: Randomized phase 2 study of pembrolizumab and carboplatin versus carboplatin alone for chest wall recurrence of breast cancer

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Multi-center randomized study of pembrolizumab/carboplatin versus carboplatin alone in patients with chest wall disease from breast cancer: TBCRC 044.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P4-09-06: Brain metastases (BM) in patients with metastatic breast cancer (MBC) and circulating cell-free DNA (cfDNA) somaticBRCAmutations

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract OT1-05-02: A phase II study to evaluate the efficacy, safety and pharmacokinetics of DHP107 (Liporaxel®, oral paclitaxel) compared to IV paclitaxel in patients with recurrent or metastatic breast cancer: OPERA (NCT03326102)

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Rising Circulating Tumor DNA As a Molecular Biomarker of Early Disease Progression in Metastatic Breast Cancer

2020
Show All
- Source
- Cite
- Save
Citations (3)
Identification of somatically acquired BRCA1/2 mutations by cfDNA analysis in patients with metastatic breast cancer

2020 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (7)